VAT credit refund policy and outward foreign direct investment: Firm‐level evidence from China
Contemporary Economic Policy · 2026-07 · 44 (3) · 717-735
DOI: 10.1111/coep.70027 ↗Kurz gefasst
Fachartikel in der Zeitschrift Contemporary Economic Policy, online erschienen am 18.03.2026. Verfasst von Qilin Mao und 1 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 34 Literaturangaben. Gefördert von: National Social Science Fund of China.
Abstract (Originalsprache)
We employ China's 2018 value‐added tax credit refund reform as a quasi‐natural experiment to investigate the policy's impact on firms' outward foreign direct investment (FDI). We find that the policy significantly promotes firms' outward FDI through improved liquidity, increased risk‐taking capacity, and heightened innovation incentives. The effect is stronger for non‐state‐owned enterprises, high‐tax‐burden firms, credit‐accumulating firms, and those with limited tax‐shifting capacity. The policy also expands outward FDI diversification across countries and industries. Additionally, we evaluate the policy's effects from a supply chain perspective, revealing that affected supplier firms can substantially enhance their customer firms' outward FDI through supply chain transmission mechanisms.
Förderung
- National Social Science Fund of China
Zitieren
APA
Mao, Q., & Wang, Y. (2026). VAT credit refund policy and outward foreign direct investment: Firm‐level evidence from China. Contemporary Economic Policy, 44(3), 717-735. https://doi.org/10.1111/coep.70027
Vancouver
Mao Q, Wang Y. VAT credit refund policy and outward foreign direct investment: Firm‐level evidence from China. Contemporary Economic Policy. 2026;44(3):717-735. doi:10.1111/coep.70027
BibTeX
@article{Mao2026,
author = {Mao, Qilin and Wang, Yueqing},
title = {VAT credit refund policy and outward foreign direct investment: Firm‐level evidence from China},
journal = {Contemporary Economic Policy},
year = {2026},
volume = {44},
number = {3},
pages = {717--735},
doi = {10.1111/coep.70027}
}
EUVIMED